A Phase I Study of Combination Anticancer Therapy of Paclitaxel and RAD001 for Relapsed or Refractory Small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 20 Aug 2013
At a glance
- Drugs Everolimus (Primary) ; Paclitaxel
- Indications Small cell lung cancer
- Focus Adverse reactions
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 Planned end date changed from 1 May 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 06 Mar 2010 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History